This content is not available in your region

Indivior posts 14% rise in quarterly profit

Access to the comments Comments
Text size Aa Aa

(Reuters) – Drugmaker Indivior Plc <INDV.L> reported a 14% rise in quarterly profit on Wednesday, as its best-selling opioid addiction drug Suboxone lost market share to generic rivals at a slower pace, than the company’s previous modelling had expected.

The maker of drugs that treat opioid addiction posted a pretax profit of $89 million (£73.2 million) in the second quarter ended June 30, from $78 million a year earlier.

(Reporting by Justin George Varghese in Bengaluru; Editing by Shounak Dasgupta)

euronews provides breaking news articles from reuters as a service to its readers, but does not edit the articles it publishes. Articles appear on for a limited time.